The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Membranous Septum Morphology Predicting the Risk of Conduction Abnormalities after Transcatheter Aortic Valve Implantation
Troels Højsgaard Jørgensen1.; Nicolaj Hansson2; Ole De Backer3; Gintautas Bieliauskas4; Christian Juhl Terkelsen2; XI Wang5; Jesper Møller Jensen2; Evald Høj Christiansen2; Nicolo Piazza6; Jesper Hastrup Svendsen3; Bjarne Linde Nørgaard2; Lars Søndergaard7;
1. Department of Cardiology, Righospitalet, Copenhagen University Hospital, Copehagen, Denmark, Denmark 2. Department of Cardiology, Aarhus University Hospital, Aarhus 3. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark;Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark 4. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 5. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China 6. Division of Cardiology, McGill University Health Center, Montreal, Canada 7. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please log in to download the PDF.
There is limited data on the association of membranous septum (MS) morphology and transcatheter heart valve (THV) implantation depth, and the development of new conduction abnormalities after transcatheter aortic valve replacement (TAVI).
To describe the morphology of the MS and predict the risk of new CA after TAVI based on the MS morphology and THV implantation depth.
Based on pre-procedural CT-scans the MS depth was measured for every 25% of the entire MS width in 272 TAVI-patients without pre-procedural bundle branch block (BBB) or pacemaker. Post-procedural CT-scans for THV implantation depth assessment were available in 130 of these patients.
The MS depth was a median of 2.5mm (IQR 1.4 – 3.8) deeper at the posterior edge when compared to the anterior edge of the MS. New CA developed in 7.1% of patients in whom the THV did not cross the lower MS border at its anterior edge (3.6% with new BBB and high degree CA, respectively); in 18.8% of patients (15.6% with new BBB and 3.1% with new high-degree CA) where the THV overlapped the lower MS border by <2.5mm and in 47.1% of patients (24.3% with new BBB and 22.9% with new high-degree CA) with THV overlap of the lower MS border by ≥2.5mm.
The difference of the MS depth and THV implantation depth measured at the anterior edge of the MS predicted new CA after TAVI.